As a graduate student, Professor Lai performed a biochemical and structural analysis of the enzyme telomerase. Following graduate school, he worked in early-stage research at Genentech where he investigated the Hedgehog signing pathway and its role in tumorigenesis. Most recently, Prof. Lai served as the head of commercial operations at the biotechnology start-up company LakePharma.
On Sabbatical in AY2021-22
Prof. Tzagarakis-Foster studies the transcription factor, DAX-1, which is a member of the nuclear hormone receptor family and is linked to the human disease X-linked Adrenal Hypoplasia Congenita (AHC). Specifically, her research explores the role of DAX-1 in human development as well its involvement in the initiation of breast cancer.